Emerging drugs for hypogonadism (Q36634275)

15 August 2017

1 reference

title

Emerging drugs for hypogonadism (English)

1 reference

15 August 2017

1 reference

Shehzad Basaria

1 reference

15 August 2017

Daniel Edelstein

1 reference

15 August 2017

Adrian Dobs

series ordinal

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 November 2006

1 reference

Expert Opinion on Emerging Drugs

15 August 2017

published in

1 reference

15 August 2017

1 reference

15 August 2017

1 reference

15 August 2017

page(s)

685-707

1 reference

Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Androgens in men--uses and abuses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Androgen replacement therapy: present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Long‐term efficacy and safety of a permeation‐enhanced testosterone transdermal system in hypogonadal men

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

The effects of exogenous testosterone on sexuality and mood of normal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Nebido: a long-acting injectable testosterone for the treatment of male hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

The Effects of Fluoxymesterone Administration on Testicular Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Hyperplasia and prolapse of hepatocytes into hepatic veins during longterm methyltestosteronetherapy: possible relationships of these changes to the development of peliosis hepatis and liver tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Osteoporosis in male hypogonadism: responses to androgen substitution differ among men with primary and secondary hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double blind controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Pharmacokinetics of a single dose of buccal testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

A comparison of a novel testosterone bioadhesive buccal system, striant, with a testosterone adhesive patch in hypogonadal males

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Short-term pharmacokinetic comparison of a novel testosterone buccal system and a testosterone gel in testosterone deficient men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Interpersonal testosterone transfer after topical application of a newly developed testosterone gel preparation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, Testim, compared to AndroGel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Testosterone substitution with a new transdermal, hydroalcoholic gel applied to scrotal or non-scrotal skin: a multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Age, Disease, and Changing Sex Hormone Levels in Middle-Aged Men: Results of the Massachusetts Male Aging Study*

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Andropause: clinical implications of the decline in serum testosterone levels with aging in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Declining gonadal function in elderly men

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

The decline of androgen levels in elderly men and its clinical and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Bone Anabolic Effects of S-40503, a Novel Nonsteroidal Selective Androgen Receptor Modulator (SARM), in Rat Models of Osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Pharmacodynamics of selective androgen receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

New nonsteroidal androgen receptor modulators based on 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g] quinolinone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Arylisothiocyanato selective androgen receptor modulators (SARMs) for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Selective androgen receptor modulators in drug discovery: medicinal chemistry and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Therapeutic potential of the SARMs: revisiting the androgen receptor for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Discovery and therapeutic promise of selective androgen receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Evidence for tissue selectivity of the synthetic androgen 7 alpha-methyl-19-nortestosterone in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Comparison of the growth-promoting effects of testosterone and 7-alpha-methyl-19-nor-testosterone (MENT) on the prostate and levator ani muscle of LPB-tag transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Bone and muscle protective potential of the prostate-sparing synthetic androgen 7alpha-methyl-19-nortestosterone: evidence from the aged orchidectomized male rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Clomiphene increases free testosterone levels in men with both secondary hypogonadism and erectile dysfunction: who does and does not benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Clomiphene citrate effects on testosterone/estrogen ratio in male hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Hypogonadotropic hypogonadal men respond less well to androgen substitution treatment than hypergonadotropic hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Therapy with human chorionic gonadotrophin alone induces spermatogenesis in men with isolated hypogonadotrophic hypogonadism--long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

A double-blind, placebo-controlled, randomized clinical trial of recombinant human chorionic gonadotropin on muscle strength and physical function and activity in older men with partial age-related androgen deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Dihydrotestosterone: a rationale for its use as a non-aromatizable androgen replacement therapeutic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Transdermal Dihydrotestosterone Treatment of 'Andropause'

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Hypogonadism in elderly men--what to do until the evidence comes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

AROMATASE INHIBITORS FOR MALE INFERTILITY

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.11.4.685

10.1517/14728214.11.4.685

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference